{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:13:57Z","timestamp":1722888837012},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00103-019-03064-z","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T10:02:47Z","timestamp":1575453767000},"page":"74-84","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reiseimpfungen","Travel vaccinations"],"prefix":"10.1007","volume":"63","author":[{"name":"St\u00e4ndiger Ausschuss Reisemedizin (StAR) der Deutschen Gesellschaft f\u00fcr Tropenmedizin und Globale Gesundheit (DTG)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Rothe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Boecken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"3064_CR1","first-page":"335","volume":"34","author":"STIKO","year":"2018","unstructured":"STIKO (2018) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull 34:335\u2013382","journal-title":"Epidemiol Bull"},{"key":"3064_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay046","author":"R Steffen","year":"2018","unstructured":"Steffen\u00a0R (2018) Travel vaccine preventable diseases-updated logarithmic scale with monthly incidence rates. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay046","journal-title":"J Travel Med"},{"issue":"02","key":"3064_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/a-0852-2732","volume":"26","author":"C Rothe","year":"2019","unstructured":"Rothe\u00a0C, Alberer\u00a0M, B\u00fchler\u00a0S et\u00a0al (2019) Reiseimpfungen \u2013 Hinweise und Empfehlungen. Flugmed Tropenmed Reisemed 26(02):58\u201379","journal-title":"Flugmed Tropenmed Reisemed"},{"key":"3064_CR4","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2019) Terminservice- und Versorgungsgesetz (TSVG). https:\/\/www.kbv.de\/media\/sp\/PraxisInfoSpezial_TSVG.pdf. Zugegriffen: 8. Juli 2019"},{"key":"3064_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","volume":"64","author":"TP Monath","year":"2015","unstructured":"Monath\u00a0TP, Vasconcelos\u00a0PF (2015) Yellow fever. J\u00a0Clin Virol 64:160\u2013173","journal-title":"J Clin Virol"},{"key":"3064_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","volume":"1","author":"TP Monath","year":"2001","unstructured":"Monath\u00a0TP (2001) Yellow fever: an update. Lancet Infect Dis 1:11\u201320","journal-title":"Lancet Infect Dis"},{"key":"3064_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-323-54696-6.00012-4","volume-title":"Travel medicine","author":"J Torresi","year":"2019","unstructured":"Torresi\u00a0J, Kollaritsch\u00a0H (2019) Recommended\/required travel vaccines. In: Keystone\u00a0JS, Kozarski\u00a0PE, Connor\u00a0BA, Nothdurft\u00a0HD, Mendelson\u00a0M, Leder\u00a0K (Hrsg) Travel medicine, S\u00a0101\u2013124"},{"key":"3064_CR8","volume-title":"World malaria report","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) World malaria report. WHO, Geneva"},{"key":"3064_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/B978-0-323-35761-6.00063-8","volume-title":"Plotkin\u2019s vaccines","author":"JE Staples","year":"2018","unstructured":"Staples\u00a0JE, Monath\u00a0TP, Gershman\u00a0MD, Barrett\u00a0ADT (2018) Yellow fever vaccines. In: Plotkin\u00a0SA, Orenstein\u00a0WA, Offit\u00a0PA, Edwards\u00a0KM (Hrsg) Plotkin\u2019s vaccines. Elsevier, Philadelphia, S\u00a01181\u20131265"},{"key":"3064_CR10","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","volume":"29","author":"JR Nascimento Silva","year":"2011","unstructured":"Nascimento Silva\u00a0JR, Camacho\u00a0LA, Siqueira\u00a0MM et\u00a0al (2011) Mutual interference on the immune response to yellow fever vaccine and a\u00a0combined vaccine against measles, mumps and rubella. Vaccine 29:6327\u20136334","journal-title":"Vaccine"},{"key":"3064_CR11","first-page":"269","volume":"88","author":"World Health Organization","year":"2013","unstructured":"World Health Organization (2013) Vaccines and vaccination against yellow fever. Wkly Epidemiol Rec 88:269\u2013284","journal-title":"Wkly Epidemiol Rec"},{"key":"3064_CR12","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","volume":"32","author":"Collaborative Group for Studies on Yellow Fever Vaccines","year":"2014","unstructured":"Collaborative Group for Studies on Yellow Fever Vaccines (2014) Duration of post-vaccination immunity against yellow fever in adults. Vaccine 32:4977\u20134984","journal-title":"Vaccine"},{"key":"3064_CR13","doi-asserted-by":"publisher","DOI":"10.17886\/EpiBull-2015-004","author":"STIKO","year":"2015","unstructured":"STIKO (2015) Wissenschaftliche Begr\u00fcndung zur \u00c4nderung der Gelbfieber-Impfempfehlung aufgrund der \u00c4nderungen in den Regelungen der Internationalen Gesundheitsvorschriften zu Gelbfieber. Epidemiol Bull. https:\/\/doi.org\/10.17886\/EpiBull-2015-004","journal-title":"Epidemiol Bull"},{"key":"3064_CR14","first-page":"647","volume":"64","author":"JE Staples","year":"2015","unstructured":"Staples\u00a0JE, Bocchini\u00a0JA Jr, Rubin\u00a0L, Fischer\u00a0M (2015) Yellow fever vaccine booster doses: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep 64:647\u2013650","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3064_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/cid\/cix960","volume":"66","author":"O Veit","year":"2018","unstructured":"Veit\u00a0O, Domingo\u00a0C, Niedrig\u00a0M et al (2018) Long-term immune response to yellow fever vaccination in Human Immunodeficiency Virus (HIV)-infected individuals depends on HIV RNA suppression status: implications for vaccination schedule. Clin Infect Dis 66:1099\u20131108","journal-title":"Clin Infect Dis"},{"key":"3064_CR16","first-page":"309","volume":"85","author":"WHO","year":"2010","unstructured":"WHO (2010) Rabies vaccines: WHO position paper. Wkly Epidemiol Rec 85:309\u2013320","journal-title":"Wkly Epidemiol Rec"},{"key":"3064_CR17","unstructured":"St\u00e4ndiger Ausschluss Reisemedizin (StAR) der DTG (2018) Aufkl\u00e4rungsmerkblatt und Einverst\u00e4ndniserkl\u00e4rung vor Impfung gegen Gelbfieber. https:\/\/dtg.org\/images\/Reiseimpfungen\/Gelbfieber-Aufklaerung-DTG_STAR_03.18.pdf. Zugegriffen: 02.12.19"},{"key":"3064_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jtm.12171","volume":"22","author":"R Steffen","year":"2015","unstructured":"Steffen\u00a0R, Behrens\u00a0RH, Hill\u00a0DR, Greenaway\u00a0C, Leder\u00a0K (2015) Vaccine-preventable travel health risks: what is the evidence \u2013 what are the gaps? J\u00a0Travel Med 22:1\u201312","journal-title":"J Travel Med"},{"key":"3064_CR19","unstructured":"Ministry of Health, Kingdom of Saudia-Arabia (2019) Health regulations concerning Meningococcal meningitis. https:\/\/www.moh.gov.sa\/en\/Hajj\/HealthGuidelines\/HealthGuidelinesDuringHajj\/Pages\/MeningococcalMeningitis.aspx. Zugegriffen: 02.12.19"},{"key":"3064_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1473-3099(17)30301-8","volume":"17","author":"CL Trotter","year":"2017","unstructured":"Trotter\u00a0CL, Lingani\u00a0C, Fernandez\u00a0K et\u00a0al (2017) Impact of MenAfriVac in nine countries of the African meningitis belt, 2010\u201315: an analysis of surveillance data. Lancet Infect Dis 17:867\u2013872","journal-title":"Lancet Infect Dis"},{"key":"3064_CR21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jadohealth.2016.04.012","volume":"59","author":"SI Pelton","year":"2016","unstructured":"Pelton\u00a0SI (2016) The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J\u00a0Adolesc Health 59:S3\u2013S11","journal-title":"J Adolesc Health"},{"key":"3064_CR22","unstructured":"Global Polio Eradication Initiative (2019) Temporary recommendations to reduce international spread of poliovirus. http:\/\/polioeradication.org\/polio-today\/polio-now\/public-health-emergency-status\/. Zugegriffen: 02.12.19"},{"key":"3064_CR23","unstructured":"Global Polio Eradication Initiative (2016) GPEI \u2013 13th report of the independent monitoring board. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/09\/14IMB_Report_EN.pdf. Zugegriffen: 02.12.19"},{"key":"3064_CR24","unstructured":"World Health Organization (2018) Statement of the 19th IHR emergency committee regarding the international spread of poliovirus. https:\/\/www.who.int\/news-room\/detail\/30-11-2018-statement-of-the-nineteenth-ihr-emergency-committee-regarding-the-international-spread-of-poliovirus. Zugegriffen: 21. Okt. 2019"},{"key":"3064_CR25","unstructured":"Gesundheitsdienst des Ausw\u00e4rtigen Amtes (2019) Poliomyelitis-Impfung. https:\/\/www.auswaertiges-amt.de\/blob\/251024\/184a41bcf886f87c8aedc5c7587eb16c\/polio-ausland-data.pdf. Zugegriffen: 21. Okt. 2019"},{"key":"3064_CR26","unstructured":"RKI (2019) Hepatitis A. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_HepatitisA.html. Zugegriffen: 21. Sept. 2019"},{"key":"3064_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3201\/eid2104.141479","volume":"21","author":"P Gautret","year":"2015","unstructured":"Gautret\u00a0P, Harvey\u00a0K, Pandey\u00a0P et al (2015) Animal-associated exposure to rabies virus among travelers, 1997\u20132012. Emerg Infect Dis 21:569\u2013577","journal-title":"Emerg Infect Dis"},{"key":"3064_CR28","doi-asserted-by":"publisher","first-page":"e2209","DOI":"10.1371\/journal.pntd.0002209","volume":"7","author":"P Carrara","year":"2013","unstructured":"Carrara\u00a0P, Parola\u00a0P, Brouqui\u00a0P, Gautret\u00a0P (2013) Imported human rabies cases worldwide, 1990\u20132012. PLoS Negl Trop Dis 7:e2209","journal-title":"PLoS Negl Trop Dis"},{"key":"3064_CR29","unstructured":"World Health Organization (2013) Frequently asked questions on rabies. https:\/\/www.who.int\/rabies\/resources\/SEA_CD_278_FAQs_Rabies.pdf. Zugegriffen: 20. Okt. 2019"},{"key":"3064_CR30","first-page":"201","volume":"93","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) Rabies vaccines \u2013 WHO position paper. Wkly Epidemiol Rec 93:201\u2013220","journal-title":"Wkly Epidemiol Rec"},{"key":"3064_CR31","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","volume":"24","author":"K Suwansrinon","year":"2006","unstructured":"Suwansrinon\u00a0K, Wilde\u00a0H, Benjavongkulchai\u00a0M et\u00a0al (2006) Survival of neutralizing antibody in previously rabies vaccinated subjects: a\u00a0prospective study showing long lasting immunity. Vaccine 24:3878\u20133880","journal-title":"Vaccine"},{"key":"3064_CR32","unstructured":"STIKO (2019) Mitteilungen der STIKO zum Impfen bei eingeschr\u00e4nkter Verf\u00fcgbarkeit von Impfstoffen. https:\/\/www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Lieferengpaesse\/Lieferengpaesse_node.html. Zugegriffen: 21. Sept. 2019"},{"key":"3064_CR33","unstructured":"StAR (2018) Neue Empfehlungen der WHO zur pr\u00e4-expositionellen Tollwutimpfung \u2013 Stellungnahme des St\u00e4ndigen Ausschusses Reisemedizin (StAR) der Deutschen Gesellschaft f\u00fcr Tropenmedizin und internationale Gesundheit (DTG). https:\/\/www.dtg.org\/images\/Aktuelles\/Mitteilungen_der-D\/Stellungnahme-des-StAR-zum-neuen-WHO-Tollwut-Impfschema.pdf. Zugegriffen: 02.12.19"},{"key":"3064_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14745\/ccdr.v40i04a01","volume":"40","author":"C Greenaway","year":"2014","unstructured":"Greenaway\u00a0C, Schofield\u00a0S, Henteleff\u00a0A et\u00a0al (2014) Summary of the statement on international travellers and typhoid by the committee to advise on tropical medicine and travel (CATMAT). Can Commun Dis Rep 40:60\u201370","journal-title":"Can Commun Dis Rep"},{"key":"3064_CR35","first-page":"467","volume":"44","author":"GEJ Falkenhorst","year":"2018","unstructured":"Falkenhorst\u00a0GEJ, Frank\u00a0C, Stark\u00a0K (2018) Reiseassoziierte Krankheiten 2017. Epidemiol Bull 44:467\u2013469","journal-title":"Epidemiol Bull"},{"key":"3064_CR36","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/cid\/ciy877","volume":"68","author":"MT Yousafzai","year":"2019","unstructured":"Yousafzai\u00a0MT, Qamar\u00a0FN, Shakoor\u00a0S et al (2019) Ceftriaxone-resistant Salmonella typhi outbreak in Hyderabad city of Sindh, Pakistan: high time for the introduction of typhoid conjugate vaccine. Clin Infect Dis 68:S16\u2013S21","journal-title":"Clin Infect Dis"},{"key":"3064_CR37","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S1473-3099(18)30350-5","volume":"19","author":"JR Andrews","year":"2019","unstructured":"Andrews\u00a0JR, Baker\u00a0S, Marks\u00a0F et\u00a0al (2019) Typhoid conjugate vaccines: a\u00a0new tool in the fight against antimicrobial resistance. Lancet Infect Dis 19:e26\u2013e30","journal-title":"Lancet Infect Dis"},{"key":"3064_CR38","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","volume":"390","author":"C Jin","year":"2017","unstructured":"Jin\u00a0C, Gibani\u00a0MM, Moore\u00a0M et al (2017) Efficacy and immunogenicity of a\u00a0Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a\u00a0controlled human infection model of Salmonella Typhi: a\u00a0randomised controlled, phase 2b trial. Lancet 390:2472\u20132480","journal-title":"Lancet"},{"key":"3064_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1477-8939(03)00062-0","volume":"1","author":"R Steffen","year":"2003","unstructured":"Steffen\u00a0R, Acar\u00a0J, Walker\u00a0E, Zuckerman\u00a0J (2003) Cholera: assessing the risk to travellers and identifying methods of protection. Travel Med Infect Dis 1:80\u201388","journal-title":"Travel Med Infect Dis"},{"key":"3064_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009029.pub2:CD009029","author":"T Ahmed","year":"2013","unstructured":"Ahmed\u00a0T, Bhuiyan\u00a0TR, Zaman\u00a0K, Sinclair\u00a0D, Qadri\u00a0F (2013) Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009029.pub2:CD009029","journal-title":"Cochrane Database Syst Rev"},{"key":"3064_CR41","volume-title":"CDC Yellow Book 2020 \u2013 Health information for international travel","author":"MD Gershman","year":"2019","unstructured":"Gershman\u00a0MD, Staples\u00a0JE (2019) Yellow fever. In: Brunette\u00a0GW, Nemhauser\u00a0JB (Hrsg) CDC Yellow Book 2020 \u2013 Health information for international travel. Oxford University Press, New York"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-019-03064-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T01:52:47Z","timestamp":1606960367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-019-03064-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3064"],"URL":"https:\/\/doi.org\/10.1007\/s00103-019-03064-z","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"type":"print","value":"1436-9990"},{"type":"electronic","value":"1437-1588"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"4 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Rothe und G.\u00a0Boecken geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}